[1] Worldometers. COVID-19 Coronaviruspandemic [EB/OL].(2021-06-01) [2021-06-01]. https://www.worldometers.info/coronavirus/. [2] Ji Y, Ma Z, Peppelenbosch MP, et al.Potential association between COVID-19 mortality and health-care resource availability[J]. Lancet Glob Health, 2020, 8(4): e480. [3] Baud D, Qi X, Nielsen-Saines K, et al.Real estimates of mortality following COVID-19 infection[J]. Lancet Infect Dis, 2020, 20(7): 773. [4] Li L, Zhang W, Hu Y, et al.Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial[J]. JAMA, 2020, 324(5): 460-470. [5] Ali S, Uddin SM, Ali A, et al.Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma[J]. Immunotherapy, 2021, 13(5): 397-407. [6] General Office of the National Health Commission. New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Edition Revised Edition) [EB/OL]. (2020-04-14)[2021-04-20]. http://www.gov.cn/zhengce/zhengceku/2021-04/15/content_5599795.htm. [7] Hansell DM, Bankier AA, Macmahon H, et al.Fleischner society: glossary of terms for thoracic imaging[J]. Radiology, 2008, 246(3): 697-722. [8] Marano G, Vaglio S, Pupella S, et al.Convalescent plasma: new evidence for an old therapeutic tool[J]. Blood Transfus, 2016, 14(2): 152-157. [9] Rabenau HF, Biesert L, Schmidt T, et al.SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation[J]. Biologicals, 2005, 33(2): 95-99. [10] Korneyeva M, Hotta J, Lebing W, et al.Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates[J]. Biologicals, 2002, 30(2): 153-162. [11] Liu X, Cao W, Li T. High-dose intravenous immunoglobulins in the treatment of severe acute viral pneumonia: the known mechanisms and clinical effects [EB/OL].(2020-07-14)[2021-05-01]. https://www.frontiersin.org/articles/10.3389/fimmu.2020.01660/full. [12] Liu L, Wang P, Nair MS, et al.Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike[J]. Nature, 2020, 584(7821): 450-456. [13] Van Dorp L, Acman M, Richard D, et al.Emergence of genomic diversity and recurrent mutations in SARS-CoV-2[J]. Infect Genet Evol, 2020, 83: 104351. [14] Xiao Y, Guo YM, Liu SY.The role of medical imaging in the diagnosis and treatment of COVID-19[J]. Chinese Journal of Radiology(中华放射学杂志), 2020, 54(4): 266-268. [15] Litjens G, Kooi T, Bejnordi BE, et al.A survey on deep learning in medical image analysis[J]. Med Image Anal, 2017, 42: 60-88. [16] Liu SY, Xiao Y.Challenges and opportunities of deep learning artificial intelligence in medical imaging[J]. Chinese Journal of Radiology(中华放射学杂志), 2017, 51(12): 899-901. [17] Cicero M, Bilbily A, Colak E, et al.Training and validating a deep convolutional neural network for computer-aided detection and classification of abnormalities on frontal chest radiographs[J]. Invest Radiol, 2017, 52(5): 281-287. [18] Lyu ZB, Guan CS, Yan S, et al.Value of CT findings in predicting transformation of clinical types of COVID-19[J]. Journal of Capital Medical University(首都医科大学学报), 2020,41(3): 340-344. |